S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation

Authors :: I. Jerome
J. Hoilland
A. Emerson
Mark T. Wagner
A. Mithoefer
B. Yazar-Klosinski
Allison A. Feduccia
Scott Hamilton
Michael C. Mithoefer
R. Doblin
Source :: European Neuropsychopharmacology. 29:S11-S12
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pharmacology
Psychiatry and Mental health
Psychotherapist
Neurology
Breakthrough therapy
business.industry
medicine
Pharmacology (medical)
MDMA
Neurology (clinical)
business
Biological Psychiatry
medicine.drug

Full Text Access

Tools